These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7945002)

  • 1. Long-term study with gabapentin in patients with drug-resistant epileptic seizures.
    Sivenius J; Ylinen A; Kälviäinen R; Riekkinen PJ
    Arch Neurol; 1994 Oct; 51(10):1047-50. PubMed ID: 7945002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabapentin as add-on therapy in children with refractory partial seizures: a 24-week, multicentre, open-label study.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Maton S; Murray G; Garofalo E
    Dev Med Child Neurol; 2001 Apr; 43(4):269-73. PubMed ID: 11305405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
    Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
    Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gabapentin monotherapy: II. A 26-week, double-blind, dose-controlled, multicenter study of conversion from polytherapy in outpatients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 82/83.
    Beydoun A; Fischer J; Labar DR; Harden C; Cantrell D; Uthman BM; Sackellares JC; Abou-Khalil B; Ramsay RE; Hayes A; Greiner M; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):746-52. PubMed ID: 9305335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The long-term safety and efficacy of gabapentin (Neurontin) as add-on therapy in drug-resistant partial epilepsy. The US Gabapentin Study Group.
    Epilepsy Res; 1994 May; 18(1):67-73. PubMed ID: 8088258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and tolerance of long-term, high-dose gabapentin: additional observations.
    Handforth A; Treiman DM
    Epilepsia; 1994; 35(5):1032-7. PubMed ID: 7925148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabapentin add-on treatment: how many patients become seizure-free? An open-label multicenter study.
    Mayer T; Schütte W; Wolf P; Elger CE
    Acta Neurol Scand; 1999 Jan; 99(1):1-7. PubMed ID: 9925232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabapentin (Neurontin) as add-on therapy in patients with partial seizures: a double-blind, placebo-controlled study. The International Gabapentin Study Group.
    Anhut H; Ashman P; Feuerstein TJ; Sauermann W; Saunders M; Schmidt B
    Epilepsia; 1994; 35(4):795-801. PubMed ID: 8082624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of Gabapentin in the treatment of partial seizures.
    Sivenius J; Kälviäinen R; Ylinen A; Riekkinen P
    Epilepsia; 1991; 32(4):539-42. PubMed ID: 1907907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gabapentin. A review of its pharmacological properties and clinical potential in epilepsy.
    Goa KL; Sorkin EM
    Drugs; 1993 Sep; 46(3):409-427. PubMed ID: 7693432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
    Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
    Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical efficacy and safety of gabapentin.
    Ramsay RE
    Neurology; 1994 Jun; 44(6 Suppl 5):S23-30; discussion S31-2. PubMed ID: 8022537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabapentin for drug-resistant partial epilepsy.
    Marson AG; Kadir ZA; Hutton JL; Chadwick DW
    Cochrane Database Syst Rev; 2000; (2):CD001415. PubMed ID: 10796785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind trial of gabapentin monotherapy for newly diagnosed partial seizures. International Gabapentin Monotherapy Study Group 945-77.
    Chadwick DW; Anhut H; Greiner MJ; Alexander J; Murray GH; Garofalo EA; Pierce MW
    Neurology; 1998 Nov; 51(5):1282-8. PubMed ID: 9818846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gabapentin monotherapy: I. An 8-day, double-blind, dose-controlled, multicenter study in hospitalized patients with refractory complex partial or secondarily generalized seizures. The US Gabapentin Study Group 88/89.
    Bergey GK; Morris HH; Rosenfeld W; Blume WT; Penovich PE; Morrell MJ; Leiderman DB; Crockatt JG; LaMoreaux L; Garofalo E; Pierce M
    Neurology; 1997 Sep; 49(3):739-45. PubMed ID: 9305334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment with gabapentin for partial epilepsy.
    Ojemann LM; Wilensky AJ; Temkin NR; Chmelir T; Ricker BA; Wallace J
    Epilepsy Res; 1992 Nov; 13(2):159-65. PubMed ID: 1464301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Gabapentin in 50 patients with epilepsy].
    Gracia-Fleta F; Medrano-Martínez V; Castaño-Pérez MD; Hernández-Lorido R; Mañes R
    Rev Neurol; 2001 Jan 1-15; 32(1):45-9. PubMed ID: 11293098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy.
    Leach JP; Girvan J; Paul A; Brodie MJ
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):372-6. PubMed ID: 9120451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
    Korn-Merker E; Borusiak P; Boenigk HE
    Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabapentin in partial epilepsy. UK Gabapentin Study Group.
    Lancet; 1990 May; 335(8698):1114-7. PubMed ID: 1971862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.